Search

Author/Creator Chicarelli, M.J.

1. In Vivo Pre-clinical characterization of a Novel Series of FGFR2 Selective Inhibitors with Potency Against Clinically Relevant Mutations. (October 2022)

Authors:
Fischer, J.; Bouhana, K.; Chicarelli, M.J.; Dahlke, J.; Fell, B.; Fulton, J.; Guarnieri, A.; Haygood, L.; Jalluri, R.; Johnson, A.; McLean, B.; Max, M.; Rieger, R.; Robinson, J.; Rodriguez, M.; Sullivan, F.; Wang, Y.; Winski, S.; Zhou, Y.
Journal:
European journal of cancer
Issue:
Volume 174(2022)Supplement 1
Page Start:
S81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pre-clinical In Vitro and In Vivo Characterization of a Novel EGFR Sparing ErbB2 Inhibitor with Activity Against Oncogenic ErbB2 Mutations. (October 2022)

Authors:
Chicarelli, M.J.; Bouhana, K.; Cable, L.; Crow, M.; Fell, B.; Fischer, J.; Fulton, J.; Guarnieri, A.; Jalluri, R.; Robinson, J.; Sullivan, F.; Winski, S.; Zhou, Y.
Journal:
European journal of cancer
Issue:
Volume 174(2022)Supplement 1
Page Start:
S81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search